Nair S, Ribas de Pouplana L, Houman F, Avruch A, Shen X, Schimmel P
Cubist Pharmaceuticals Inc., Cambridge, MA 02139, USA.
J Mol Biol. 1997 May 30;269(1):1-9. doi: 10.1006/jmbi.1997.1025.
In spite of variations in the sequences of tRNAs, the genetic code (anticodon trinucleotides) is conserved in evolution. However, non-anticodon nucleotides which are species specific are known to prevent a given tRNA from functioning in all organisms. Conversely, species-specific tRNA contact residues in synthetases should also prevent cross-species acylation in a predictable way. To address this question, we investigated the relatively small tyrosine tRNA synthetase where contacts of Escherichia coli tRNA(Tyr) with the alpha2 dimeric protein have been localized by others to four specific sequence clusters on the three-dimensional structure of the Bacillus stearothermophilus enzyme. We used specific functional tests with a previously not-sequenced and not-characterized Mycobacterium tuberculosis enzyme and showed that it demonstrates species-specific aminoacylation in vivo and in vitro. The specificity observed fits exactly with the presence of the clusters characteristic of those established as important for recognition of E. coli tRNA. Conversely, we noted that a recent analysis of the tyrosine enzyme from the eukaryote pathogen Pneumocystis carinii showed just the opposite species specificity of tRNA recognition. According to our alignments, the sequences of the clusters diverge substantially from those seen with the M. tuberculosis, B. stearothermophilus and other enzymes. Thus, the presence or absence of species-specific residues in tRNA synthetases correlates in both directions with cross-species aminoacylation phenotypes, without reference to the associated tRNA sequences. We suggest that this kind of analysis can identify those synthetase-tRNA covariations which are needed to preserve the genetic code. These co-variations might be exploited to develop novel antibiotics against pathogens such as M. tuberculosis and P. carinii.
尽管转运RNA(tRNA)的序列存在差异,但遗传密码(反密码子三核苷酸)在进化过程中是保守的。然而,已知物种特异性的非反密码子核苷酸会阻止特定的tRNA在所有生物体中发挥作用。相反,合成酶中物种特异性的tRNA接触残基也应以可预测的方式阻止跨物种的酰化作用。为了解决这个问题,我们研究了相对较小的酪氨酸tRNA合成酶,其他人已将大肠杆菌tRNA(Tyr)与α2二聚体蛋白的接触定位到嗜热脂肪芽孢杆菌酶三维结构上的四个特定序列簇。我们对一种先前未测序和表征的结核分枝杆菌酶进行了特定的功能测试,结果表明它在体内和体外都表现出物种特异性的氨酰化作用。观察到的特异性与那些被确定对识别大肠杆菌tRNA很重要的簇的存在完全吻合。相反,我们注意到最近对真核病原体卡氏肺孢子虫酪氨酸酶的分析显示出与tRNA识别相反的物种特异性。根据我们的比对,这些簇的序列与结核分枝杆菌、嗜热脂肪芽孢杆菌和其他酶的序列有很大差异。因此,tRNA合成酶中物种特异性残基的有无在两个方向上都与跨物种氨酰化表型相关,而不考虑相关的tRNA序列。我们认为这种分析可以识别那些维持遗传密码所需的合成酶 - tRNA共变。这些共变可能被用于开发针对结核分枝杆菌和卡氏肺孢子虫等病原体的新型抗生素。